Astraea Therapeutics

Astraea Therapeutics

Pharmaceuticals, 320 Logue Ave, Mountain View, California, 94043, United States, 1-10 Employees

astraeatherapeutics.com

  • LinkedIn

phone no Phone Number: 65********

Who is ASTRAEA THERAPEUTICS

From addiction biology to empowering patients Astraea Therapeutics is a clinical-stage company developing life-changing medicines for patients fighting to overcome substance addiction to ...

Read More

map
  • 320 Logue Ave, Mountain View, California, 94043, United States Headquarters: 320 Logue Ave, Mountain View, California, 94043, United States
  • 2009 Date Founded: 2009
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from ASTRAEA THERAPEUTICS

Astraea Therapeutics Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Astraea Therapeutics

Answer: Astraea Therapeutics's headquarters are located at 320 Logue Ave, Mountain View, California, 94043, United States

Answer: Astraea Therapeutics's phone number is 65********

Answer: Astraea Therapeutics's official website is https://astraeatherapeutics.com

Answer: Astraea Therapeutics's revenue is $1 Million to $5 Million

Answer: Astraea Therapeutics's SIC: 2834

Answer: Astraea Therapeutics has 1-10 employees

Answer: Astraea Therapeutics is in Pharmaceuticals

Answer: Astraea Therapeutics contact info: Phone number: 65******** Website: https://astraeatherapeutics.com

Answer: From addiction biology to empowering patients Astraea Therapeutics is a clinical-stage company developing life-changing medicines for patients fighting to overcome substance addiction to opioid painkillers, smoking, and habitual psychostimulants. Astraeas platform technology centers around the neurobiology of relapse. Astraea is developing oral medicines that focus on two key pathways in the brain, one genetically linked to addictive behaviors and the other shown by clinical imaging to be altered in patients struggling with addiction.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access